The S-carboxymethyl-D-cysteine side-chain analogs of cephalosporin C and deacetoxycephalosporin C were found to have markedly increased in vitro activity against Gram-positive and Gram-negative bacteria compared to the natural antibiotics.
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The S-carboxymethyl-Lcysteine analogs were less active than the S-carboxymethyl-n-cysteine analogs but against most organisms tested, still more active than the natural compounds. The effect of replacement of CH, with S was less dramatic in the case of penicillin N and isopenicillin N. The S-carboxymethyl-D-cysteine analog of deacetoxycephalosporin C was found to be orally available in rats.
Isopenicillin N synthetase ("cyclase" )1), catalyzes the ring cyclization of the tripeptide 8-(L-aaminoadipyl)-L-cysteinyl-D-valine (ACV) to isopenicillin N. Studies of the substrate specificity of this enzyme have led to the in vitro production of new penicillins and cephalosporins by the technique of enzymatic biosynthesis2-8). We have recently isolated the enzyme in pure form from both Cephalosporium acremonium9) and Streptornyces clavuligerus (unpublished data). The cyclases from C. acremonium2,4) and S. clavuligerus3) yield penicillins and cephalosporins in which a CH2 group in the side-chain is replaced by sulfur when the analog tripeptide S-(S-carbonylmethyl-L-cysteine)-L-cysteinyl-D-valine is employed as substrate in place of ACV. Because of the lability of the isopenicillin N epimerase of C. acremonium, the fungal preparation stops at the stage of the penicillin analogs2,4). However, the S. clavuligerus epimerase is more stable3), and cell-free experiments with this organism proceed to cephalosporin analogs. The present work is concerned with the in vitro activities of these antibiotics and reveals a marked increase in activity resulting from substitution of CH2 by S in the side-chain.
Materials and Methods
The antibiotics used in this study were synthesized from the appropriate 6-amino or 7-amino precursor, as described by BOWERS, et a1.3). Minimum inhibitory concentrations (pg/disc) of the antibiotics were determined by an agar diffusion assay using 6.5 mm paper discs to apply the antibiotic.
Alternatively, minimum inhibitory concentrations (tag/ml) were also determined by broth dilution assay. The purity of each penicillin was determined by the chemical procedure of HOLM10) using ampicillin as a standard.
A modified assay was devised (C. LUBBE and A. L. DEMAIN, in preparation) using En- terobacter cloacae ~-lactamase instead of Bacillus penicillinase to determine purity of cephalosporins. Cephalosporin C was used as the standard in this case. Oral availability studies were conducted using male Sprague Dawley rats (approx 300 g). Antibiotics were administered in aqueous solution at 50 mg/kg body weight. Blood was drawn into citrate containing syringes 1 hour after administration of the antibiotics. One hundred and fifty microliter amounts of plasma (four replicates) were bioassayed by agar diffusion assay on 12.7 mm paper discs using Escherichia coli Ess as the indicator organism.
Results
Activities of isopenicillin N, penicillin N, deacetoxycephalosporin C, cephalosporin C and their sulfur analogs are shown in Table 1 . In general, it can be seen that substitution of S for CH2 in the side-chain having the D-configuration results in a marked increase in biological activity against both
Gram-positive and Gram-negative bacteria.
The effect of replacing S by CH2 in the side-chain is seen (Table 1) Both antibiotics were absorbed and plasma samples gave similar zones of inhibition ( Table 3 ). The greater sensitivity of the indicator organism to CMC-DAOC as compared to cephalexin, however, meant that the plasma concentration of cephalexin was actually much higher (average 17 µg/ml) than that of CMC-DAOC (average 0.37 l-tg/ml ). Table 3 . Oral availability of deacetoxycephalosporin C (S analog) and cephalexin. It is noteworthy that the sulfur analog of penicillin N, RIT 2214, was obtained some years ago11)
when a lysine auxotroph of C. acremonium was supplied with S-carboxymethyl-L-cysteine. Although the in vitro activity of RIT 2214 was not impressive, the compound was found to be more active in vivo than ampicillin, presumably due to higher plasma concentrations.
In semi-synthetic cephamycins12), the S-carboxymethyl-D-cysteine side-chain also confers high levels of in vitro activity and an even higher level of in vivo activity. The present study is consistent with the findings11,12) that in vitro activity is not markedly altered by the analog side-chain in penicillins but is markedly increased in cephalosporins.
Although estimates of in vivo activity were not attempted in the present work, the oral availability of CMC-DAOC makes this compound deserving of continued investigation, since lack of oral availability is a major drawback of most current semi-synthetic cephalosporins.
The ease of preparation of cephalosporins containing the S-carboxymethyl-D-cysteine side-chain may make enzymatic synthesis a viable alternative to chemical synthesis7).
